The incidence and course of pulmonary hypertension in systemic lupus erythematosus patients. Three years follow up outcome

Abstract

The increased incidence of secondary APS, antiphospholipid antibodies, anti-ds DNA antibodies, pulmonary. Treatment of SLE had no effect on already established PH.

Keywords

• systemic lupus erythematosus
• pulmonary hypertension
• vasculopathy
• antiphospholipid antibodies
• pulmonary embolism
• organ manifestation
• heart failure
• therapy